Here are some essential questions to ask your doctor so you can make an informed decision: Am I a good candidate for GLP-1 therapy based on my health conditions
GLP-1 medication use spiked, as well
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, at higher doses (as Wegovy), for weight management in adults with obesity
Truy cp ngy 13 thng 04 nm 2025
These effects appear to be more pronounced in aged than in younger subjects (n = 21, age 4875) (Mahdi et al., 2019), and does not depend on efficacy of blood glucose-lowering therapy in T2D patients (n = 16, average age 64) (Mahdi et al., 2018)
If you have any concerns or need guidance during your treatment, dont hesitate to reach out to your Centra Internal Medicine care team